Compound index

Small-Molecule Drugs

Minoxidil

FDA-approved for specific indicationsFDA-approved

Last reviewed: 2026-11-19

Overview

A small-molecule drug with distinct cardiovascular and dermatologic approved products.

Regulatory status

FDA approval applies only to the named products and indications below. It does not approve every formulation or other use.

  • Rogaine · Hair Loss

    Regrowth of hair in the product-specific labeled adult male or female pattern-hair-loss population; not an approval of all minoxidil forms for this use.

    Authoritative label record

Status as of 2026-11-19. Regulations change. Check FDA.gov for current information.

WADA prohibited status: current list and context

Evidence at a glance

Product-specific approvals do not imply that one formulation is approved for another formulation’s indication.

Key sources

Indication-specific regulatory sources and editorial screen checked November 19, 2026. This is not an exhaustive systematic review; consult current labels.

Related compounds

  • Apomorphine

    Same scientific class · A small chemical molecule, not a peptide. · FDA-approved for specific indications

  • Finasteride

    Same scientific class · A small chemical molecule, not a peptide. · FDA-approved for specific indications

  • Metformin

    Same scientific class · A small chemical molecule, not a peptide. · FDA-approved for specific indications

  • Methylthioninium chloride

    Same scientific class · A small chemical molecule, not a peptide. · FDA-approved for specific indications

  • Omeprazole

    Same scientific class · A small chemical molecule, not a peptide. · FDA-approved for specific indications

Related glossary terms